Molecular Diagnostics

Newsletter
100 Pages
April 2024
Region: Global
Citeline
ID: 5642912

Molecular diagnostics is being applied to an increasingly wide range of applications in infectious disease, oncology, and genetic disease diagnosis and screening, and to a number of emerging applications. The market for molecular diagnostics products totaled nearly $21bn in 2021. Following a projected downturn in 2022 and 2023 due to a decline in COVID-19 testing, the market is expected to return to growth in 2024. Drivers of the market will include adoption of new types of tests, expansion of target populations for molecular testing, and advances in the level of diagnostic testing services provided, particularly in developing countries.

This new report includes a discussion of products, current/forecast markets, competitors, and opportunities in the molecular diagnostics products markets for the US, 5 Euro (France, Germany, Italy, Spain, and UK), Japan, and Rest of World markets. The forecast range for this report is 2021-26.

This medical market and technology report provides a comprehensive discussion of the market for molecular diagnostics. This market consists of in vitro molecular diagnostics solutions, instrument systems, reagents, and services (maintenance and repair). Product segments included within this market comprise those used for the following clinical applications: blood screening, genetic testing, infectious disease, oncology, and other.

Markets covered by this analysis comprise the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the rest of world (RoW) markets, which includes all other countries.

This report provides the following useful information:

Epidemiology of selected diseases
Blood collection trends
An overview of molecular diagnostics technology, including companion diagnostics
Product portfolios offered by leading manufacturers
In-depth market and competitive analyses

Executive Summary

i. Molecular diagnostics market

a. Molecular diagnostics for infectious disease testing
b. Molecular diagnostics for oncology testing
c. Molecular diagnostics for genetic testing
d. Molecular diagnostics for blood screening
e. Molecular diagnostics for other applications

ii. Market drivers and limitersiii. Technology trendsiv. Market leadersv. Competitive strategiesvi. Emerging competition

vii. Methodology

Exhibit ES-1: Molecular diagnostics products, combined market forecast, by region ($m), 2021-26
Exhibit ES-2: Molecular diagnostics products, combined market forecast, by clinical application ($m), 2021-26

1. Molecular Diagnostics Clinical Overview

1.1 Molecular diagnostics for infectious disease testing
1.1.1 Hepatitis B virus
1.1.2 Hepatitis C virus
1.1.3 Human immunodeficiency virus
1.1.4 Tuberculosis
1.1.5 Chlamydia trachomatis/Neisseria gonorrhea
1.1.6 Human papillomavirus
1.1.7 Methicillin-resistant Staphylococcus aureus
1.1.8 Novel coronavirus (COVID-19)
1.1.9 Other infectious diseases
1.2 Molecular diagnostics for oncology testing
1.2.1 Prostate cancer
1.2.2 Breast cancer
1.2.3 Colorectal cancer
1.2.4 Other cancers
1.3 Molecular diagnostics for genetic testing
1.4 Molecular diagnostics for blood screening
1.5 Molecular diagnostics for other applications
1.5.1 Cardiovascular disease
1.5.2 Diabetes
1.5.3 Other applications
1.6 Bibliography

Exhibit 1-1: Epidemiology of selected infectious diseases, by region
Exhibit 1-2: Daily SARS-CoV-2 molecular test volume in the US
Exhibit 1-3: Incidence of selected cancer types, by region, 2020
Exhibit 1-4: Incidence of selected cancer types, by region, 2040
Exhibit 1-5: Epidemiology of selected genetic diseases, by region
Exhibit 1-6: Blood collection trends, by region, 2017-20
Exhibit 1-7: Cardiovascular disease mortality, by region, 2014-19
Exhibit 1-8: Prevalence of diabetes, by region (000s), 2019-45
Exhibit 1-9: Organ transplantation procedures, by region, 2016-21

2. Molecular Diagnostics Products

2.1 Technology insights
2.1.1 Polymerase chain reaction
2.1.2 Hybridization
2.1.3 Next-generation sequencing
2.1.4 Microarray technologies
2.1.5 Other technologies
2.2 Molecular diagnostics products for infectious disease testing
2.3 Molecular diagnostics products for oncology testing
2.4 Molecular diagnostics products for genetic testing
2.5 Molecular diagnostics products for blood screening
2.6 Molecular diagnostics products for other applications
2.7 Bibliography

Exhibit 2-1: Selected molecular diagnostics products for infectious disease testing, 2022
Exhibit 2-2: Selected molecular diagnostics products for oncology testing, 2022
Exhibit 2-3: Selected molecular diagnostics products for genetic testing, 2022
Exhibit 2-4: Selected molecular diagnostics products for blood screening, 2022
Exhibit 2-5: Selected molecular diagnostics products for other applications, 2022

3. Molecular Diagnostics Market

3.1 Regional insights
3.1.1 US
3.1.2 Five major European markets
3.1.3 Japan
3.1.4 Rest of world
3.2 Molecular diagnostics, market forecast segmented by product type
3.2.1 Competitive analysis
3.3 Trends in the molecular diagnostics market
3.3.1 Reimbursement/economic trends
3.3.2 Laboratory-developed tests
3.4 Market drivers and limiters
3.5 Molecular diagnostics for infectious disease testing, market analysis
3.5.1 Competitive analysis
3.6 Molecular diagnostics for oncology testing, market analysis
3.6.1 Competitive analysis
3.7 Molecular diagnostics for genetic testing, market analysis
3.7.1 Competitive analysis
3.8 Molecular diagnostics for blood screening, market forecast
3.8.1 Competitive analysis
3.9 Molecular diagnostics for other applications, market forecast
3.9.1 Competitive analysis
3.10 Bibliography

Exhibit 3-1: Molecular diagnostics products, combined market forecast, by region ($m), 2021-26
Exhibit 3-2: Molecular diagnostics products, combined market forecast, by clinical application ($m), 2021-26
Exhibit 3-3: Molecular diagnostics products, combined market, global share by supplier, 2021
Exhibit 3-4: Molecular testing services/laboratory-developed tests market, by company ($m), 2019-21
Exhibit 3-5: Molecular diagnostics products for infectious disease testing, market forecast, by region ($m), 2021-26
Exhibit 3-6: Molecular diagnostics products for infectious disease testing, global share by supplier, 2021
Exhibit 3-7: Molecular diagnostics for oncology testing, market forecast, by region ($m) 2021-26
Exhibit 3-8: Molecular diagnostics for oncology testing, global share by supplier, 2021
Exhibit 3-9: Molecular diagnostics for genetic testing, market forecast, by region ($m), 2021-26
Exhibit: Molecular diagnostics for genetic testing, global share by supplier, 2021
Exhibit: Molecular diagnostics for blood screening, market forecast, by region ($m), 2021-26
Exhibit: Molecular diagnostics for blood screening, global share by supplier, 2021
Exhibit: Molecular diagnostics for other applications, market forecast, by region ($m), 2021-26
Exhibit: Molecular diagnostics for other applications, share by supplier, 2021

APPENDIX: COMPANY LISTING

This report provides the following useful information:

Table of Contents

Related Topics

Related Products

Molecular Diagnostics - Global Strategic Business Report

U.S. Molecular Diagnostics Market Size, Share & Trends Analysis Report By Disease (Healthcare-associated Infections, Respiratory), By End-use (Hospital Core Laboratory, Decentralized Test Sites), And Segment Forecasts, 2023 - 2030

North America Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Others), By Test Location, By Technology (PCR, ISH, INAAT, Sequencing), By Application, By Country, And Segment Forecasts, 2024 - 2030

Global Molecular Diagnostics Market by Technology (Chips and Microarrays, In Situ Hybridization, Mass Spectrometry (MS)), Product (Instruments, Reagents), Application, End User - Forecast 2024-2030

The World Market for Molecular Diagnostics, 12th Edition